Toxicity and feasibility of adjuvant high-dose interferon alpha-2b in patients with melanoma in clinical oncologic practice

To assess the feasibility and toxicity profile of high-dose interferon alpha-2b (IFN-α-2b) in the adjuvant treatment of patients with cutaneous malignant melanoma outside the reference ECOG 1684 clinical trial, we conducted a prospective follow-up in an identical population of patients (cutaneous me...

Descripción completa

Detalles Bibliográficos
Autores principales: Ravaud, A, Bedane, C, Geoffrois, L, Lesimple, T, Delaunay, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1999
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363131/
https://www.ncbi.nlm.nih.gov/pubmed/10468294
http://dx.doi.org/10.1038/sj.bjc.6690595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363131/
https://www.ncbi.nlm.nih.gov/pubmed/10468294
http://dx.doi.org/10.1038/sj.bjc.6690595

Ejemplares similares